Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
An announcement from EKSO BIONICS ( (EKSO) ) is now available.
On February 15, 2026, Ekso Bionics entered into a Contribution and Exchange Agreement with subsidiaries of Applied Digital Corporation to acquire all of Applied Digital Cloud Corporation in exchange for issuing 138,216,820 new Ekso shares, with closing targeted for the second quarter of 2026. Upon completion, Cloud will become a wholly owned subsidiary, Ekso will be renamed ChronoScale Corporation, and the Contributor is expected to own about 97% of the combined company before further transactions, significantly diluting legacy Ekso shareholders and cementing Applied Digital’s control.
The deal is subject to customary conditions including stockholder approval, SEC clearance of an information or proxy statement, minimum cash of $15 million including a planned PIPE financing, Nasdaq listing approval, and adoption of new charter documents that notably expand authorized shares and entrench governance rights for Applied Digital. An Investor Rights Agreement will give Applied Digital the right to designate a majority of the board while it holds a controlling stake, along with extensive consent, preemptive and registration rights, and recent bylaw and charter changes further reinforce its influence over ChronoScale’s capital structure and board composition.
The most recent analyst rating on (EKSO) stock is a Hold with a $8.00 price target. To see the full list of analyst forecasts on EKSO BIONICS stock, see the EKSO Stock Forecast page.
Spark’s Take on EKSO Stock
According to Spark, TipRanks’ AI Analyst, EKSO is a Neutral.
The score is held back primarily by weak financial performance (large ongoing losses and continued cash burn) despite strong TTM revenue growth and improving leverage. Technicals are a key positive with the price in an uptrend and momentum not overheated, while valuation is hard to assess with negative earnings. Corporate events add some upside potential via added funding and a possible strategic pivot, but with meaningful execution and dilution uncertainty.
To see Spark’s full report on EKSO stock, click here.
More about EKSO BIONICS
Ekso Bionics Holdings, Inc., a Nevada corporation, operates in the technology sector and is known for its work in advanced systems, but is now repositioning itself through a strategic business combination. Following the transaction, the company will be renamed ChronoScale Corporation and will become the parent of a combined enterprise that includes Applied Digital’s cloud-focused subsidiary, Applied Digital Cloud Corporation.
Average Trading Volume: 2,225,378
Technical Sentiment Signal: Buy
Current Market Cap: $33.49M
Learn more about EKSO stock on TipRanks’ Stock Analysis page.